NCT04833712View on ClinicalTrials.gov

Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2022

Conditions
Atrial FibrillationArrythmiaCardiovascular DiseasesHeart Arrhythmia
Interventions
RADIATION

Stereotactic Radioablation

Stereotactic Radioablation targets on the pulmonary vein ostium aiming to achieve PVI

Trial Locations (2)

Unknown

RECRUITING

Attikon University Hospital, Chaïdári

RECRUITING

Mediterraneo Hospital, Glyfada

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

National and Kapodistrian University of Athens

OTHER